Medtronic views Stealth Axis as the ‘cornerstone’ of AiBLE, the company’s surgical workflow ecosystem.
Medtronic (NYSE:MDT) announced today that the FDA cleared its Stealth AXiS surgical robotic system for new indications.
The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.
South Coast doctors perform first nose-based brain tumour surgery, marking a major KZN breakthrough and improving access to ...
US FDA clears Medtronic’s Stealth AXiS surgical system for cranial and ENT procedures: Galway, Ireland Monday, March 30, 2026, 10:00 Hrs [IST] Medtronic, a global leader in heal ...